Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04341961 · ClinicalTrials.gov registry record · NA

Effect of Pomegranate Juice Consumption on the Health of Mothers and Infants During Breastfeeding

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
11
Enrollment target

NCT04341961 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 11 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04341961, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

Breast milk is universally recognized as the best food for newborns. Studies have scientifically shown that breastfeeding provides optimal nutrients for infants, strengthens their immune system, and improves mother-and-child bonding. Demonstrating health benefits of pomegranate consumption on infant health could lead to greater incentive for women to breast feed. The purpose of this research study is to determine whether pomegranate metabolites (products produced by breakdown) is secreted into breastmilk and whether they have an effect on breast-fed infants who are born vaginally.

Interventions

  • OTHER Pomegranate Juice

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2019-05-08
Est. Completion 2020-07-31
Phase NA

What the Registry Record Tells You About NCT04341961

The ClinicalTrials.gov registry entry for NCT04341961 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pomegranate Juice is the first listed.

NCT04341961 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04341961 about?

NCT04341961 is a clinical study titled "Effect of Pomegranate Juice Consumption on the Health of Mothers and Infants During Breastfeeding". Breast milk is universally recognized as the best food for newborns. Studies have scientifically shown that breastfeeding provides optimal nutrients for infants, strengthens their immune system, and improves mother-and-child bonding. Demonstrating health benefits of pomegranate consumption on infant...

What is the current status of trial NCT04341961?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2019-05-08. Estimated completion is 2020-07-31.

What interventions are being tested in trial NCT04341961?

The interventions under investigation include: Pomegranate Juice (OTHER).

Who is sponsoring clinical trial NCT04341961?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.